About Garuda TX
Garuda TX is a company based in Natick (United States) founded in 2021 by David Scadden and Sean Morrison. Garuda TX has raised $181.83 million across 3 funding rounds from investors including ARE, Resilience and Orbimed. The company has 53 employees as of December 31, 2023. Garuda TX operates in a competitive market with competitors including Biogen, CareDx, ADMA Biologics, Kymeratx and BioNTech, among others.
- Headquarter Natick, United States
- Employees 53 as on 31 Dec, 2023
- Founders David Scadden, Sean Morrison
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Garuda Therapeutics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$181.83 M (USD)
in 3 rounds
-
Latest Funding Round
$47.71 M (USD), Series B
Oct 17, 2024
-
Investors
ARE
& 10 more
-
Employee Count
53
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Garuda TX
Unlock access to complete
Unlock access to complete
Funding Insights of Garuda TX
Garuda TX has successfully raised a total of $181.83M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $47.71 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Garuda TX
Garuda TX has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include ARE, Resilience and Orbimed.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in life sciences & tech sectors
|
Locked | Locked | Locked | |
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Locked | Locked | Locked | |
|
PE firm investing in the US
|
Locked | Locked | Locked |
Investor details for Garuda TX
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Garuda TX
Investment portfolio details for Garuda TX
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Garuda TX
Detailed financials for Garuda TX
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Garuda Tx Comparisons
Peer comparison for Garuda TX
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Garuda TX
Garuda TX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogen, CareDx, ADMA Biologics, Kymeratx and BioNTech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapies for neurodegenerative and immunology disorders are developed.
|
|
| Locked | Locked | Locked |
Medical solutions for transplant patients are developed and provided.
|
|
| Locked | Locked | Locked |
Plasma-based biologics are developed for immune deficiency and infectious diseases.
|
|
| Locked | Locked | Locked |
Small molecule protein degraders are developed for various disorders.
|
|
| Locked | Locked | Locked |
Immunotherapeutics for cancer and other diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
Detailed competitors of Garuda TX
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Garuda Tx
Complete news archive for Garuda TX
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Garuda TX
Garuda TX was founded in 2021.
Garuda TX is headquartered in Natick, United States. It is registered at Natick, Massachusetts, United States.
Garuda TX is a funded company, having raised a total of $181.83M across 3 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Garuda TX is 53.
Stem cell-based therapies are developed by Garuda, founded in 2021 and based in Natick, United States, within the biotechnology sector. Operations focus on stem cell transplants enhanced by targeted antibodies and self-renewal pathway modulation to increase cell numbers. The pipeline addresses hematologic malignancies, sickle cell disease, β-thalassemia, bone marrow failure conditions, and additional indications. Co-founders include David Scadden and Sean Morrison.
Garuda TX's top competitors include CareDx, ADMA Biologics and BioNTech.
Garuda TX has 11 investors. Key investors include ARE, Resilience, Orbimed, Monashee Investment Management, and Northpond Ventures.